LIPO: Lipella Pharmaceuticals Inc. Common Stock Company Profile & Statistics

About

Lipella Pharmaceuticals Inc. is a clinical-stage biotechnology company. It focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Lipella Pharmaceuticals Inc. is based in PITTSBURGH.

Info & Links

CEO

Jonathan Kaufman

Headquarters

7800 SUSQUEHANNA ST., SUITE 505
PITTSBURGH, PA 15208, UNITED STATES

Auditor

Urish Popeck & Co., LLC

Share holders

Employees

Lipella Pharmaceuticals Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

3.87M

Enterprise Value

2.51M

Enterprise Value/EBITDA(ttm)

-0.58

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

8.56

Price to Book(mrq)

2.83

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-882.82%

Profit Margin(ttm)

-967.99%

Return on Equity(ttm)

-192.33%

Return on Invested Capital(ttm)

-222.52%

Return on Assets(ttm)

-154.24%

Income Statement

Revenue(ttm)

483.50K

Revenue Per Share(ttm)

0.40

Gross Profit(ttm)

483.50K

EBITDA(ttm)³

-4.36M

Net Income Available to Common(ttm)

-4.26M

Diluted EPS(ttm)

-4.25

Share Statistics

Beta (5Y Monthly)

0.28

52-Week Change

-57.67%

S&P 500 52-Week Change

18.16%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

1.21M

Dividend Yield

0.00%

Float⁴

821.00K

% Held by Insiders

32.11%

% Held by Institutions

74.31%

Balance Sheet

Total Cash(mrq)

1.35M

Total Cash Per Share(mrq)

1.12

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.97%

Quick Ratio(mrq)

2.97%

Book Value Per Share(mrq)

1.34

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.65

Free Cash Flow(ytd)

-2.96M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

LIPO

Lipella Pharmaceuticals Inc. Common Stock

Lipella Pharmaceuticals Inc. Common Stock Profile